Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Figures corrected NBB
Corrected annual account filed for 2022.
Financials
Financial year 2025
Curium International from Brussel, company number BE0860215596, closed financial year 2025 with a result of € 2.9 million after tax. For that financial year Curium International recorded revenue of € 3.5 million and equity of € 53.4 million. Compared with financial year 2024, the result moved from € -284,425 to € 2.9 million. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 3, 2026.
€ 53.4 million
▲ 6% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 2.9 million
▲ still € 284,425 loss in 2024
Profit after tax over the fiscal year.
€ 19,616
▼ 61% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 31.9 million.
People and assets in 2025
€ 6,808
▼ 42% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1.6 million
▲ 19% vs 2024
Supplier invoices still open on the last day of the fiscal year. Pays suppliers within 163 days on average.
€ 563,723
▲ € 506,082 vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Revenue | € 3,373,030 | € 3,636,127 | € 3,247,467 | € 3,457,160 | ▲ 6% |
| Profit after taxes | € 1,207,302 | € 4,960,434 | € -284,425 | € 2,873,133 | ▲ € 3.2 million |
| Equity | € 44,258,365 | € 49,218,799 | € 50,531,469 | € 53,404,602 | ▲ 6% |
| Total debts | € 9,375,743 | € 9,851,249 | € 9,254,040 | € 14,036,005 | ▲ 52% |
| Cash | € 209,381 | € 3,776,543 | € 49,798 | € 19,616 | ▼ 61% |
| Retained profit | € 24,258,354 | € 29,218,787 | € 29,031,708 | € 31,904,841 | ▲ 10% |
| Balance sheet total | € 53,634,108 | € 59,070,048 | € 59,785,509 | € 67,440,607 | ▲ 13% |
Key figures of Curium International, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Curium International?
What happened at Curium International in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Xavier DEFOURT stepped down as director. NBB
- Guillaume TALLANDIER stepped down as director. NBB
- New annual accounts for financial year 2025: profit of € 2.9 million. filed late Source: NBB ↗
- Guillaume TALLANDIER became a director. NBB
- Xavier DEFOURT became a director. NBB
- Start of the company according to the CBE. KBO
- New establishment in Brussel. KBO
In short
From € 1.2 million profit in 2022 to € 2.9 million profit in 2025.
Paid € 2.3 million in corporate taxes since 2022.
Best year ever: 2023, with € 5 million profit.
Pays suppliers within 163 days on average.
A new publication or filing at Curium International? We notify you, reason included.
Follow Curium InternationalDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The shares are held by Curium Bidco SARL (100%). It owns 100% of Curium Pet Liège SA, 100% of IBA MOLECULAR TURKEY, 100% of IBA MOLECULAR UK LTD, 100% of Curium Pharma India Private Limited, 75% of BETAPLUS PHARMA SA and 50.3% of Bio Molecular Industries Sdn BHD itself.
Directors
According to the 2025 annual accounts
Guillaume TALLANDIER
Director
since 2023 · until 2027
Xavier DEFOURT
Director
Also active at: XABEDO, BETAPLUS PHARMA, Curium PET Liège, IBA PHARMA INVESTMENTS
since 2018 · until 2028
Shareholders
Curium Bidco SARL
100%
Participations
100%
IBA MOLECULAR TURKEY
100%
IBA MOLECULAR UK LTD
100%
Curium Pharma India Private Limited
100%
Bio Molecular Industries Sdn BHD
50.3%
Swan Isotopes AG
5.4%
Curiumpharma Mexico SA de CV
Establishments
Establishment units
Physical locations of this company
Bischoffsheimlaan 39 box 4
1000 Brussel
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0860.215.596
- VAT number
- BE 0860.215.596
- Registered office
- Bischoffsheimlaan 39 bus 4, 1000 Brussel
- Names & denominations
- Curium International
- Enterprise type
- Rechtspersoon
- Legal form
- Public limited company
- Legal situation
- Normale toestand
- Start date
- 22 August 2003
- Peppol
- Active · Active since 30 Dec 2025
- Activities · NACE
Activiteiten van ingenieurs en aanverwante technische adviseurs, exclusief landmeters-experts
Technische studiën en ingenieursactiviteiten